Actively Recruiting
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking
Led by Kaiser Permanente · Updated on 2026-04-30
800
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
Sponsors
K
Kaiser Permanente
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to compare the effectiveness of two smoking cessation programs to determine which better helps people change their smoking behavior, the control or the experimental intervention? Both interventions include access to a mHealth app and other publicly available stop-smoking resources. The two app versions each include best practice advice and guidance for quitting smoking, but one includes additional content designed for people who aren't ready to quit smoking. The investigators hypothesize that people who receive the experimental intervention will be more likely to request additional stop-smoking resources offered through the intervention and report smoking abstinence after 6 months. The investigators also hypothesize people assigned to the experimental app will have better app engagement and be more likely to report positive changes in their smoking behavior and use of other evidence-based stop smoking treatments that are publicly available.
CONDITIONS
Official Title
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age and older
- Current cigarette smoker who is ambivalent about smoking
- Not actively using any treatment to quit smoking
- Own and regularly use a smartphone
- Willing to install and use the assigned app
- Willing to receive study communications
- Smoke at least half a pack a day
- Meet geolocation requirements
You will not qualify if you...
- Lifetime history of dementia or psychosis
- Visual impairments preventing phone content viewing without adaptive devices
- Medical contraindications for over-the-counter nicotine replacement therapy use
- Other exclusions to prevent fraudulent enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Kaiser Permanente Center for Health Research
Portland, Oregon, United States, 97227
Actively Recruiting
Research Team
J
Jennifer B McClure, PhD
CONTACT
A
Anna C Edelmann, MScN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here